Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOD1 | Q9Y239 | 3/20 | 0.39 |
| ▸ | FAAH | O00519 | 3/20 | 0.37 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.37 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.37 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.37 |
| ▸ | PLA2G4A | P47712 | 1/20 | 0.37 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.37 |
| ▸ | SPHK1 | Q9NYA1 | 4/20 | 0.36 |
| ▸ | RRM1 | P23921 | 1/20 | 0.36 |
| ▸ | SPHK2 | Q9NRA0 | 1/20 | 0.36 |
| ▸ | CASP2 | P42575 | 1/20 | 0.36 |
| ▸ | EPHX1 | P07099 | 2/20 | 0.35 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4273265 | 1.00 | NOD1 (0.39) | NOD1FAAHFFAR4FFAR1PLA2G2A | |
| SCHEMBL4274227 | 1.00 | NOD1 (0.39) | NOD1FAAHFFAR4FFAR1PLA2G2A | |
| SCHEMBL4272225 | 1.00 | NOD1 (0.39) | NOD1FAAHFFAR4FFAR1PLA2G2A | |
| SCHEMBL4274209 | 1.00 | NOD1 (0.39) | NOD1FAAHFFAR4FFAR1PLA2G2A | |
| SCHEMBL4272219 | 1.00 | NOD1 (0.39) | NOD1FAAHFFAR4FFAR1PLA2G2A | |
| SCHEMBL4280766 | 1.00 | NOD1 (0.39) | NOD1FAAHFFAR4FFAR1PLA2G2A | |
| SCHEMBL4273271 | 1.00 | NOD1 (0.39) | NOD1FAAHFFAR4FFAR1PLA2G2A | |
| SCHEMBL4267962 | 1.00 | NOD1 (0.39) | NOD1FAAHFFAR4FFAR1PLA2G2A | |
| SCHEMBL4271371 | 1.00 | NOD1 (0.39) | NOD1FAAHFFAR4FFAR1PLA2G2A | |
| SCHEMBL4271358 | 1.00 | NOD1 (0.39) | NOD1FAAHFFAR4FFAR1PLA2G2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7608250-B2 | Cosmetic composition | AJINOMOTO CO., INC. (JP) | 2009-10-27 | — | — | US | disclosed |
| US-20060029626-A1 | Cosmetic composition | AJINOMOTO CO., INC. (JP) | 2006-02-09 | — | — | US | disclosed |
| US-20030165448-A1 | Cosmetic composition | AJINOMOTO CO., INC. (JP) | 2003-09-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030165448-A1 | Cosmetic composition | CUTA, ARGLU1, ASS1 | NOD1 4534/4885FAAH 172/4885FFAR4 772/4885 |
| US-20060029626-A1 | Cosmetic composition | CUTA, NGLY1, ARG1 | NOD1 4286/4885FAAH 231/4885FFAR4 534/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.